Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Pomerantz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cancer Journal (Sudbury, Mass.)|December 14, 2011
The genetics of cancer riskMark M Pomerantz, Matthew L Freedman
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Genetics of prostate cancer riskMark M Pomerantz, Matthew L Freedman
Cancer Treatment Reviews|March 19, 2015
Sequencing current therapies in the treatment of metastatic prostate cancerLoana B Valenca, Christopher J Sweeney, Mark M Pomerantz
American Journal of Human Genetics|February 1, 2020
Allele-Specific QTL Fine Mapping with PLASMAAustin T Wang, Anamay Shetty, Edward O'Connor, et al.
American Journal of Human Genetics|October 26, 2021
Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanismsAnamay Shetty, Ji-Heui Seo, Connor A Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate CancerXiaodong Wang, Lauren C Harshman, Wanling Xie, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 MutationsZsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, et al.
Clinical Epigenetics|May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancerTesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|December 14, 2011
The genetics of cancer riskMark M Pomerantz, Matthew L Freedman
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Genetics of prostate cancer riskMark M Pomerantz, Matthew L Freedman
Cancer Treatment Reviews|March 19, 2015
Sequencing current therapies in the treatment of metastatic prostate cancerLoana B Valenca, Christopher J Sweeney, Mark M Pomerantz
American Journal of Human Genetics|February 1, 2020
Allele-Specific QTL Fine Mapping with PLASMAAustin T Wang, Anamay Shetty, Edward O'Connor, et al.
American Journal of Human Genetics|October 26, 2021
Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanismsAnamay Shetty, Ji-Heui Seo, Connor A Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate CancerXiaodong Wang, Lauren C Harshman, Wanling Xie, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 MutationsZsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, et al.
Clinical Epigenetics|May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancerTesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
Pageof 7